vs

APPFOLIO INC(APPF)与Ultragenyx Pharmaceutical Inc.(RARE)财务数据对比。点击上方公司名可切换其他公司

APPFOLIO INC的季度营收约是Ultragenyx Pharmaceutical Inc.的1.3倍($262.2M vs $207.3M),APPFOLIO INC净利率更高(16.2% vs -62.0%,领先78.2%),Ultragenyx Pharmaceutical Inc.同比增速更快(25.9% vs 20.4%),过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高(38.0% vs 15.3%)

AppFolio Inc.是一家2006年成立的美国企业,专注服务房地产行业,为客户提供软件即服务(SaaS)类应用产品及相关配套服务,助力房地产相关经营主体优化管理流程、提升运营效率。

Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业,专注于研发罕见病和超罕见遗传病的创新治疗方案,这类疾病目前大多无获批疗法,存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台,研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。

APPF vs RARE — 直观对比

营收规模更大
APPF
APPF
是对方的1.3倍
APPF
$262.2M
$207.3M
RARE
营收增速更快
RARE
RARE
高出5.4%
RARE
25.9%
20.4%
APPF
净利率更高
APPF
APPF
高出78.2%
APPF
16.2%
-62.0%
RARE
两年增速更快
RARE
RARE
近两年复合增速
RARE
38.0%
15.3%
APPF

损益表 — Q1 FY2026 vs Q4 FY2025

指标
APPF
APPF
RARE
RARE
营收
$262.2M
$207.3M
净利润
$42.4M
$-128.6M
毛利率
营业利润率
19.4%
-54.7%
净利率
16.2%
-62.0%
营收同比
20.4%
25.9%
净利润同比
35.2%
3.5%
每股收益(稀释后)
$1.18
$-1.28

绿色 = 该指标领先。财年不对齐时期间可能不同

8季度营收与利润趋势

并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配

营收
APPF
APPF
RARE
RARE
Q1 26
$262.2M
Q4 25
$248.2M
$207.3M
Q3 25
$249.4M
$159.9M
Q2 25
$235.6M
$166.5M
Q1 25
$217.7M
$139.3M
Q4 24
$203.7M
$164.6M
Q3 24
$205.7M
$139.5M
Q2 24
$197.4M
$147.0M
净利润
APPF
APPF
RARE
RARE
Q1 26
$42.4M
Q4 25
$39.9M
$-128.6M
Q3 25
$33.6M
$-180.4M
Q2 25
$36.0M
$-115.0M
Q1 25
$31.4M
$-151.1M
Q4 24
$102.7M
$-133.2M
Q3 24
$33.0M
$-133.5M
Q2 24
$29.7M
$-131.6M
营业利润率
APPF
APPF
RARE
RARE
Q1 26
19.4%
Q4 25
17.6%
-54.7%
Q3 25
14.1%
-106.9%
Q2 25
17.2%
-64.8%
Q1 25
15.5%
-102.6%
Q4 24
11.3%
-74.3%
Q3 24
20.7%
-94.6%
Q2 24
18.3%
-79.1%
净利率
APPF
APPF
RARE
RARE
Q1 26
16.2%
Q4 25
16.1%
-62.0%
Q3 25
13.5%
-112.8%
Q2 25
15.3%
-69.0%
Q1 25
14.4%
-108.5%
Q4 24
50.4%
-80.9%
Q3 24
16.0%
-95.7%
Q2 24
15.0%
-89.5%
每股收益(稀释后)
APPF
APPF
RARE
RARE
Q1 26
$1.18
Q4 25
$1.10
$-1.28
Q3 25
$0.93
$-1.81
Q2 25
$0.99
$-1.17
Q1 25
$0.86
$-1.57
Q4 24
$2.79
$-1.34
Q3 24
$0.90
$-1.40
Q2 24
$0.81
$-1.52

资产负债表与财务实力

最新季度各公司的流动性、杠杆与账面价值一览

指标
APPF
APPF
RARE
RARE
现金及短期投资手头流动性
$147.4M
$421.0M
总债务越低越好
股东权益账面价值
$470.2M
$-80.0M
总资产
$580.6M
$1.5B
负债/权益比越低杠杆越低

8季度趋势,按日历期对齐

现金及短期投资
APPF
APPF
RARE
RARE
Q1 26
$147.4M
Q4 25
$107.0M
$421.0M
Q3 25
$76.1M
$202.5M
Q2 25
$73.5M
$176.3M
Q1 25
$56.9M
$127.1M
Q4 24
$42.5M
$174.0M
Q3 24
$62.4M
$150.6M
Q2 24
$59.6M
$480.7M
股东权益
APPF
APPF
RARE
RARE
Q1 26
$470.2M
Q4 25
$542.6M
$-80.0M
Q3 25
$498.9M
$9.2M
Q2 25
$455.6M
$151.3M
Q1 25
$462.1M
$144.2M
Q4 24
$519.3M
$255.0M
Q3 24
$412.8M
$346.8M
Q2 24
$371.4M
$432.4M
总资产
APPF
APPF
RARE
RARE
Q1 26
$580.6M
Q4 25
$689.0M
$1.5B
Q3 25
$640.5M
$1.2B
Q2 25
$567.4M
$1.3B
Q1 25
$564.7M
$1.3B
Q4 24
$626.7M
$1.5B
Q3 24
$523.3M
$1.5B
Q2 24
$479.3M
$1.6B

现金流与资本效率

扣除再投资后实际产生的现金。现金流比净利润更难造假

指标
APPF
APPF
RARE
RARE
经营现金流最新季度
$34.3M
$-99.8M
自由现金流经营现金流 - 资本支出
$-100.8M
自由现金流率自由现金流/营收
-48.6%
资本支出强度资本支出/营收
0.5%
现金转化率经营现金流/净利润
0.81×
过去12个月自由现金流最近4个季度
$-472.0M

8季度趋势,按日历期对齐

经营现金流
APPF
APPF
RARE
RARE
Q1 26
$34.3M
Q4 25
$65.0M
$-99.8M
Q3 25
$86.0M
$-91.4M
Q2 25
$52.6M
$-108.3M
Q1 25
$38.5M
$-166.5M
Q4 24
$36.6M
$-79.3M
Q3 24
$57.8M
$-67.0M
Q2 24
$50.9M
$-77.0M
自由现金流
APPF
APPF
RARE
RARE
Q1 26
Q4 25
$63.7M
$-100.8M
Q3 25
$84.7M
$-92.7M
Q2 25
$52.4M
$-110.7M
Q1 25
$38.2M
$-167.8M
Q4 24
$36.4M
$-79.5M
Q3 24
$57.4M
$-68.6M
Q2 24
$50.8M
$-79.0M
自由现金流率
APPF
APPF
RARE
RARE
Q1 26
Q4 25
25.7%
-48.6%
Q3 25
34.0%
-58.0%
Q2 25
22.2%
-66.5%
Q1 25
17.6%
-120.5%
Q4 24
17.9%
-48.3%
Q3 24
27.9%
-49.2%
Q2 24
25.8%
-53.7%
资本支出强度
APPF
APPF
RARE
RARE
Q1 26
Q4 25
0.5%
0.5%
Q3 25
0.5%
0.8%
Q2 25
0.1%
1.5%
Q1 25
0.1%
1.0%
Q4 24
0.1%
0.1%
Q3 24
0.2%
1.2%
Q2 24
0.0%
1.4%
现金转化率
APPF
APPF
RARE
RARE
Q1 26
0.81×
Q4 25
1.63×
Q3 25
2.56×
Q2 25
1.46×
Q1 25
1.23×
Q4 24
0.36×
Q3 24
1.75×
Q2 24
1.71×

财务流量对比

营收 → 毛利润 → 营业利润 → 净利润流向图

业务分部营收拆解

APPF
APPF

Value Added Services$201.4M77%
Subscription Services$58.2M22%

RARE
RARE

Royalty$105.6M51%
Products$101.7M49%

相关对比